HNN3.0
Register
Register
Register

Project cooperationUpdated on 22 December 2025

Postbitic for glycemic control (type 2 diabetes, prediabetes)

R&D Manager at GENBIOMA

Pamplona, Spain

About

Genbioma is a start-up that studies the microbiome to create products that improve cardiometabolic health.

Health Solutions

G​enbioma advances metabolic wellness with postbiotic ingredients that restores gut-microbiota balance to steady glucose, harmonise lipid profiles and support healthy weight. Our most advanced product is intended for type 2 diabetes and prediabetes. Other products in our pipeline are aimed at lipid metabolism.

Research platform

Genbioma has validated a development platform for rapid identification and functional profiling of new microbiome-based solutions.

  • Array of validated assays for glucose, lipid and cardiovascular metabolism using C. elegans model.

  • Integrated metagenomics & metabolomics to unveil mode-of-action early.

  • Regulatory filters baked in: Safety, IP and regulatory checkpoints for early candidate de-selection.

Expertise

Microbiome study. Postbiotics, probiotics. Preclinical and clinical studies. Metagenomics.

Similar opportunities

  • Project cooperation

    Microbiome, Multi-Omics, and Drosophila Models for Sex/Gender-Aware Precision Prevention in Cardiometabolic and Brain Health

    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches

    Jordi Mayneris Perxachs

    Group Leader - R4 at GIRONA BIOMEDICAL RESEARCH CENTRE (IDIBGI)

    Girona, Spain

  • Project cooperation

    Health projects at Eurecat

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    MARTA SANS VALLS

    European Programme Manager at Fundacio Eurecat

    Barcelona, Spain

  • Project cooperation

    Vascular Biology and Metabolic Regulation in Cardiometabolic Diseases

    • Partner seeks Consortium/Coordinator

    Andrea Szuchman-Sapir

    Head of vascular signaling group at Migal

    Kiryat Shmona, Israel